OTC医薬品、医療機器、診断薬の世界市場

Report Highlights

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

OTC医薬品、医療機器、診断薬の世界市場は、2024年の2,517億ドルから2029年までに3,597億ドルに達し、2024年から2029年までの年間平均成長率（CAGR）は7.4%になると推定されています。

Report Scope:

The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.

Report Synopsis

Report Includes:

– 36 data tables and 69 additional tables

– An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics

– Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region

– Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management

– A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)

– A discussion on ESG challenges and practices in the industry

– Review of patents issued for OTC drugs, medical devices, and diagnostics

– Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews

– Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments

– Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Introduction

Types of OTC Products

Pharmaceutical OTC Drugs

Vitamin and Mineral Supplements

OTC Medical Devices and Diagnostics

Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics

Cost Savings Analysis

PESTLE Analysis

Porter’s Five Forces Analysis

Bargaining Power of Buyers: High

Bargaining Power of Suppliers: Moderate

Potential of New Entrants to the Market: Moderate

Competition in the Industry: High

Threat of Substitutes: Moderate to High

Regulatory Landscape

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Chapter 3 Market Dynamics

Market Dynamics

Market Drivers

Growing Prevalence of Chronic Diseases and Expanding Geriatric Populations

Increasing Health Awareness

Growing Online Sales Channels and Telehealth Platforms

Market Restraints

Presence of Alternative Methods

Market Opportunities

Emerging Economies

Market Challenges

Misuse and Interactions of OTC Drugs and Medical Devices

Data Privacy and Security Concerns

Chapter 4 Emerging Technologies and Developments

Emerging Technologies

Advanced Drug Delivery

Advanced Wearable Sensors

Artificial Intelligence

Clinical Trials Analysis

Clinical Trials Analysis by Type of Study

Clinical Trials Analysis, by Status

Clinical Trials Analysis, by Phase

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown

Market Analysis by Product

OTC Drugs

Pharmaceutical Drugs

Vitamin and Mineral Supplements

OTC Devices and Diagnostics

Monitoring Devices

Therapeutic Devices

Diagnostic Devices and Kits

Market Breakdown by Application

Respiratory Disorders

Gastrointestinal Disorders

Orthopedic Diseases

Cardiovascular Diseases

Diabetes

Skin Disorders

Obesity

ENT Disorders

Sleep Disorders

Other Disorders

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 6 Competitive Intelligence

Market Analysis

Strategic Analysis

Chapter 7 Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective

Introduction to ESG

Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective

Key ESG Issues

OTC Drug, Medical Device, and Diagnostics ESG Performance Analysis

Concluding Remarks from BCC

Chapter 8 Appendix

Methodology

Sources

Abbreviations

Company Profiles

ABBOTT

BAYER AG

DSM-FIRMENICH

HALEON GROUP OF CO.

KENVUE

KONINKLIJKE PHILIPS N.V.

MASIMO

NESTLE

PROCTER & GAMBLE

SANOFI

List of Tables

Summary Table : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, Through 2029

Table 1 : Difference between Prescription v/s OTC Pharmaceutical Drugs

Table 2 : Top OTC Pharmaceutical Drugs in Major Categories

Table 3 : Top Vitamin and Mineral Supplements in Major Categories

Table 4 : Top OTC Medical Devices and Diagnostics in Major Categories

Table 5 : FDA Medical Device Classification

Table 6 : EU MDR Medical Device Classification

Table 7 : Asia-Pacific: Regulatory Landscape

Table 8 : RoW: Regulatory Landscape

Table 9 : Global: Leading causes of Disease Burden, 2022 v/s 2050

Table 10 : U.S.: Sufferers Using Only OTC Products, 2019

Table 11 : Comparison of FDA-Cleared Health Monitoring Watches

Table 12 : OTC Drugs: Adverse Effects

Table 13 : OTC Drug Interaction with Disorders

Table 14 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Type of Study, October 2024

Table 15 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Status, October 2024

Table 16 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Phase, October 2024

Table 17 : OTC Drugs, Medical Devices and Diagnostics Inclusion, by Product

Table 18 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product, Through 2029

Table 19 : Global Market for OTC Drugs, by Region, Through 2029

Table 20 : Global Market for OTC Drugs, by Type, Through 2029

Table 21 : Most Common OTC Cough, Cold and Respiratory Drugs

Table 22 : Most Common OTC Analgesic/Antipyretic

Table 23 : Most Common OTC Gastrointestinal Drugs

Table 24 : Most Common OTC Dermatological Drugs

Table 25 : Key Marketed OTC Pharmaceutical Drugs, by Company

Table 26 : Global Market for Pharmaceutical Drugs, by Region, Through 2029

Table 27 : Key Marketed Vitamin and Mineral Supplements, by Company

Table 28 : Global Market for Vitamin and Mineral Supplements, by Region, Through 2029

Table 29 : Global Market for OTC Devices and Diagnostics, by Region, Through 2029

Table 30 : Global Market for OTC Devices and Diagnostics, by Type, Through 2029

Table 31 : OTC Cardiac Monitoring Devices, by Company

Table 32 : OTC Blood Pressure Monitoring Devices, by Company

Table 33 : OTC Pulse Oximeter, by Company

Table 34 : OTC Glucose Monitoring Devices, by Company

Table 35 : OTC Sleep Monitoring Devices, by Company

Table 36 : Fetal Monitoring Devices, by Company

Table 37 : Global Market for Monitoring Devices, by Region, Through 2029

Table 38 : Pain Management Devices, by Company

Table 39 : Rehabilitation Devices, by Company

Table 40 : Other OTC Devices, by Company

Table 41 : Global Market for Therapeutic Devices, by Region, Through 2029

Table 42 : Diagnostic Devices and Kits, by Company

Table 43 : Global Market for Diagnostic Devices and Kits, by Region, Through 2029

Table 44 : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Application, Through 2029

Table 45 : Global Market for Respiratory Disorders, by Region, Through 2029

Table 46 : Gastrointestinal Disorders: OTC Drug Management

Table 47 : Global Market for Gastrointestinal Disorders, by Region, Through 2029

Table 48 : Global Market for Orthopedic Diseases, by Region, Through 2029

Table 49 : Global Market for Cardiovascular Diseases, by Region, Through 2029

Table 50 : Worldwide Diabetes Estimates (20-79 Years), by Region, 2021-2045

Table 51 : Global Market for Diabetes, by Region, Through 2029

Table 52 : Global Market for Skin Disorders, by Region, Through 2029

Table 53 : Global Market for Obesity, by Region, Through 2029

Table 54 : Global Market for ENT Disorders, by Region, Through 2029

Table 55 : Global Market for Sleep Disorders, by Region, Through 2029

Table 56 : Global Market for Other Disorders, by Region, Through 2029

Table 57 : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Region, Through 2029

Table 58 : North American Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029

Table 59 : European Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029

Table 60 : Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029

Table 61 : OTC Pharmaceutical Drugs: Market Player Share Analysis, 2023

Table 62 : OTC Drugs, Medical Devices, and Diagnostics: Recent Strategic Developments, 2022-2024

Table 63 : ESG Rankings for OTC Drug, Medical Device, and Diagnostics Companies, 2024*

Table 64 : ESG: Environmental Overview

Table 65 : ESG: Social Overview

Table 66 : ESG: Governance Overview

Table 67 : Report Specific Information Sources

Table 68 : Abbreviations Used in OTC Drugs, Medical Devices, and Diagnostics Market

Table 69 : Abbott: Company Snapshot

Table 70 : Abbott: Financial Performance, FY 2022 and 2023

Table 71 : Abbott: Product Portfolio

Table 72 : Abbott: News/Key Developments, 2021-2024

Table 73 : Bayer AG: Company Snapshot

Table 74 : Bayer AG: Financial Performance, FY 2022 and 2023

Table 75 : Bayer AG: Product Portfolio

Table 76 : DSM-Firmenich: Company Snapshot

Table 77 : DSM-Firmenich: Financial Performance, FY 2022 and 2023

Table 78 : DSM-Firmenich: Product Portfolio

Table 79 : DSM-Firmenich: News/Key Developments, 2023

Table 80 : Haleon Group of Co.: Company Snapshot

Table 81 : Haleon Group of Co.: Financial Performance, FY 2022 and 2023

Table 82 : Haleon Group of Co.: Product Portfolio

Table 83 : Haleon Group of Co.: News/Key Developments, 2023 and 2024

Table 84 : Kenvue: Company Snapshot

Table 85 : Kenvue: Financial Performance, FY 2022 and 2023

Table 86 : Kenvue: Product Portfolio

Table 87 : Koninklijke Philips N.V.: Company Snapshot

Table 88 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023

Table 89 : Koninklijke Philips N.V.: Product Portfolio

Table 90 : Masimo: Company Snapshot

Table 91 : Masimo: Financial Performance, FY 2022 and 2023

Table 92 : Masimo: Product Portfolio

Table 93 : Masimo: News/Key Developments, 2024

Table 94 : Nestle: Company Snapshot

Table 95 : Nestle: Financial Performance, FY 2022 and 2023

Table 96 : Nestle: Product Portfolio

Table 97 : Nestle: News/Key Developments, 2024

Table 98 : Procter & Gamble: Company Snapshot

Table 99 : Procter & Gamble: Financial Performance, FY 2022 and 2023

Table 100 : Procter & Gamble: Product Portfolio

Table 101 : Sanofi: Company Snapshot

Table 102 : Sanofi: Financial Performance, FY 2022 and 2023

Table 103 : Sanofi: Product Portfolio

Table 104 : Sanofi: News/Key Developments, 2023 and 2024

List of Figures

Summary Figure : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, 2021-2029

Figure 1 : Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics

Figure 2 : OTC Drugs, Medical Devices, and Diagnostics: PESTLE Analysis

Figure 3 : Market Dynamics of OTC Drugs, Medical Devices, and Diagnostics

Figure 4 : Global Population Share Above 65 Years, 2019-2023

Figure 5 : Security Risk of Wearable

Figure 6 : Emerging Trends/Technologies in the OTC Drugs, Medical Device and Diagnostics Market

Figure 7 : Global Market Shares for OTC Drugs, Medical Devices and Diagnostics, by Product, 2023

Figure 8 : Global Market Shares for OTC Drugs, by Type, 2023

Figure 9 : Global Market Shares for OTC Devices and Diagnostics, by Type, 2023

Figure 10 : Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Application, 2023

Figure 11 : Percentage of Population Aged 65 Years and Above, by Region, 2050

Figure 12 : Worldwide Diabetes Estimates (20–79 Years), by Region, 2021, 2030 and 2045

Figure 13 : Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Region, 2023

Figure 14 : North American Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023

Figure 15 : U.S. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 16 : Canadian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 17 : European Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023

Figure 18 : German Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 19 : U.K. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 20 : French Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 21 : Italian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 22 : Rest of European Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029

Figure 23 : Asia-Pacific Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023

Figure 24 : Chinese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 25 : Indian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 26 : Japanese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 27 : Rest of Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 28 : Rest of the World Market for OTC Drugs, Medical Devices, and Diagnostics, 2021–2029

Figure 29 : Major Vitamin and Mineral Supplements Players

Figure 30 : Major OTC Medical Device Players

Figure 31 : ESG Pillars

Figure 32 : Advantages of ESG for Companies

Figure 33 : Key ESG Issues in the OTC Drug, Medical Device, and Diagnostics Industry

Figure 34 : Abbott: Revenue Shares, by Business Unit, FY 2023

Figure 35 : Abbott: Revenue Shares, by Country/Region, FY 2023

Figure 36 : Bayer AG: Revenue Shares, by Business Unit, FY 2023

Figure 37 : Bayer AG: Revenue Shares, by Country/Region, FY 2023

Figure 38 : DSM-Firmenich: Revenue Shares, by Business Unit, FY 2023

Figure 39 : DSM-Firmenich: Revenue Shares, by Country/Region, FY 2023

Figure 40 : Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2023

Figure 41 : Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2023

Figure 42 : Kenvue: Revenue Shares, by Business Unit, FY 2023

Figure 43 : Kenvue: Revenue Shares, by Country/Region, FY 2023

Figure 44 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023

Figure 45 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023

Figure 46 : Masimo: Revenue Shares, by Business Unit, FY 2023

Figure 47 : Masimo: Revenue Shares, by Country/Region, FY 2023

Figure 48 : Nestle: Revenue Shares, by Business Unit, FY 2023

Figure 49 : Nestle: Revenue Shares, by Country/Region, FY 2023

Figure 50 : Procter & Gamble: Revenue Shares, by Business Unit, FY 2023

Figure 51 : Procter & Gamble: Revenue Shares, by Country/Region, FY 2023

Figure 52 : Sanofi: Revenue Shares, by Business Unit, FY 2023

Figure 53 : Sanofi: Revenue Shares, by Country/ Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧